This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Austin Sydnor, Jr, MD; Jack M. Gwaltney, Jr, MD; David M. Cocchetto, PhD; W. Michael Scheld, MD

Arch Otolaryngol Head Neck Surg. 1989;115(12):1430-1433.

Abstract
• Cefuroxime axetil, a new β–lactamase-stable cephalosporin, was compared with cefaclor for the treatment of acute bacterial maxillary sinusitis in 106 adult patients. Direct sinus aspirations for quantitative bacterial culture were done for all patients before treatment; aspiration was repeated for most patients after treatment. Pretreatment sinus aspirates were positive for 63 of 134 sampled sinuses. Of specimens yielding at least 104 CFU/mL, Haemophilus Influenzae (38%) and Streptococcus pneumoniae (37%) were the most common pathogens. Ten (42%) of 24 strains of Hinfluenzae, 2 (40%) of 5 Haemophilus parainfluenzae, and all 3 isolates (60%) of Branhamella catarrhalis produced β-lactamase. Cefuroxime axetil, 250 mg twice a day, was compared with cefaclor, 500 mg three times a day. Among culture-positive sinuses, bacteriologic cure was achieved in 36 (95%) of 38 sinuses and 15 (71%) of 21 sinuses treated with cefuroxime axetil and cefaclor, respectively. The overall frequencies of adverse events were similar between drugs, although cefuroxime axetil was associated with more frequent diarrhea. Cefuroxime axetil was an effective therapy for the treatment of acute bacterial maxillary sinusitis in adults.

(Arch Otolaryngol Head Neck Surg. 1989;115:1430-1433)

Author Affiliations
From the Department of Otolaryngology, Martha Jefferson Hospital, Charlottesville, Va (Dr Sydnor); the Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville (Drs Gwaltney and Scheld); Glaxo Inc, Research Triangle Park, NC (Dr Cocchetto); and the Department of Neurosurgery, University of Virginia School of Medicine, Charlottesville (Dr Scheld).

Footnotes
Accepted for publication June 21, 1989.

Presented in part at the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, Calif, October 1988.

Reprint requests to 1000 E High St, Suite A, Charlottesville, VA 22901 (Dr Sydnor).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Randomized Controlled Trial of 3 vs 10 Days of Trimethoprim/Sulfamethoxazole for Acute Maxillary Sinusitis
Williams et al.
JAMA 1995;273:1015-1021.
ABSTRACT  

Cefuroxime Axetil in the Treatment of Sinusitis: A Review
Paker et al.
Arch Fam Med 1994;3:165-175.
ABSTRACT  

Cefaclor vs Amoxicillin in the Treatment of Acute, Recurrent, and Chronic Sinusitis
Huck et al.
Arch Fam Med 1993;2:497-503.
ABSTRACT